Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvals
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Join us for an insightful session on how our single-tube NGS solution can provide a complete genetic profile for thalassemia testing within 24 hours, reducing laboratory workflow time by weeks and significantly shortening the time to completion of the full clinical workflow.
Dr. Thessalia Papasavva, from the Cyprus Institute of Neurology and Genetics, will share her experiences in fully implementing an NGS solution in their routine lab for thalassemia genetic testing. Join us as we discuss new ways of working, experiences, and considerations from implementing NGS in routine labs, and NGS data analysis simplified with customized software.
During the webinar we will discuss:
News | September 06, 2023
Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding BrazilNews | July 17, 2023
Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvalsNews | June 29, 2023
Devyser launches two new genetic testing solutions for hereditary cancerDevyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Read More
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Read More
Collaboration and distribution agreement with Thermo Fisher Scientific Thermo Fisher Scientific...
Read More
As a lab manager, you know the importance of streamlining workflows to maximize productivity and...
Read More